Skip to main content
SpringerLink
Log in

Chronic Pelvic Pain of Urogynecologic Origin

  • Chapter
  • First Online:
Urogenital Pain

  • 834 Accesses

Abstract

Pelvic pain encountered in urogynecology is a dilemma that can frustrate even the most patient of providers. Managing these conditions can be even more bewildering as they require a multidisciplinary approach in most cases. Interstitial cystitis/bladder pain syndrome (IC/BPS) is the most common etiology of pelvic pain seen in urogynecology. Diet and lifestyle modifications in addition to physical therapy, biofeedback, medications, surgery, and integrative medicine modalities can be used alone or in combination to relieve symptoms and should be individualized after proper evaluation and diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Berry SH, Elliott MN, Suttorp M, Bogart LM, Stoto MA, Eggers P, Nyberg L, Clemens JQ. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol. 2011;186(2):540–4.

    Article  PubMed  PubMed Central  Google Scholar 

  2. http://www.niddk.nih.gov.

  3. Jonsson Funk M, Edenfield AL, Pate V, Visco AG, Weidner AC, WU JM. Trends in use of surgical mesh for pelvic organ prolapse. Am J Obstet Gynecol. 2013;208(1):79.e1–7.

    Article  PubMed  Google Scholar 

  4. FDA Public Health Notification: serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse. Issued: 20 Oct 2008 at http://www.fda.gov/medicaldevices/safety/alertsandnotices/publichealthnotifications/ucm061976.htm.

  5. FDA Safety Communication: update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse. Issued on 13 July 2011 at http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm262435.htm.

  6. https://clinicaltrials.gov.

  7. Gauruder-Burmester A, Koutouzidou P, Rohne J, Gronewold M, Tunn R. Follow-up after polypropylene mesh repair of anterior and posterior compartments in patients with recurrent prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18:1059–64.

    Article  CAS  PubMed  Google Scholar 

  8. Feiner B, Maher C. Vaginal mesh contraction: definition, clinical presentation, and management. Obstet Gynecol. 2010;115(2 Pt 1):325–30.

    Article  PubMed  Google Scholar 

  9. Lin LL, Haessler AL, Ho MH, Betson LH, Alinsod RM, Bhatia NN. Dyspareunia and chronic pelvic pain after polypropylene mesh augmentation for transvaginal repair of anterior vaginal wall prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18(6):675–8.

    Article  PubMed  Google Scholar 

  10. Reed BD, Harlow SD, Sen A, et al. Prevalence and demographic characteristics of vulvodynia in a population-based sample. Am J Obstet Gynecol. 2012;206:170.e1–9.

    Article  PubMed  Google Scholar 

  11. Vulvodynia. ACOG Committee Opinion No. 345. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2006;108:1049–52. (9. Edwards L. Vulvodynia. Clin Obstet Gynecol. 58(1):143–52).

    Google Scholar 

  12. Bulun SE. Endometriosis mechanisms of disease. N Engl J Med. 2009;360(3):268–79.

    Article  CAS  PubMed  Google Scholar 

  13. Hanno P, Lin A, Nordling J, et al. Bladder pain syndrome committee of the international consultation on incontinence. Neurourol Urodyn. 2010;29:191–8.

    Article  PubMed  Google Scholar 

  14. Wein AJ, Hanno PM, Gillenwater JY. Interstitial cystitis: an introduction to the problem. In: Hanno PM, Stasking DR, Krane RJ, editors. Interstitial cystitis. London: Springer; 1990.

    Google Scholar 

  15. Hanno PM, Landis JR, Matthews-Cook Y, et al. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health interstitial cystitis database study. J Urol. 1999;161(2):553–7.

    Article  CAS  PubMed  Google Scholar 

  16. Castro-Diaz D, Cardozo L, Chapple CR, et al. Urgency and pain in patients with overactive bladder and bladder pain syndrome. What are the differences? Int J Clin Pract. 2014;68(3):356–62.

    Article  CAS  PubMed  Google Scholar 

  17. Bologna RA, Whitmore KE. Hypersensitivity disorders of the lower urinary tract. In: Walters MD, editor. Urogynecology and reconstructive pelvic surgery. 4th ed. Philadelphia: Elsevier; 2015.

    Google Scholar 

  18. Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases workshop on interstitial cystitis, National Institutes of Health, Bethesda, MD, August 28–29, 1987. J Urol. 1988;140:203–6.

    CAS  PubMed  Google Scholar 

  19. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function. Report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–78.

    Article  PubMed  Google Scholar 

  20. Van der Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;3:60–8.

    Article  Google Scholar 

  21. Hanno P, Dmochowski R. Status of international consensus on interstitial cystitis/bladder pain syndrome/painful bladder syndrome: 2008 snapshot. Neurourol Urodyn. 2009;28:274–86.

    Article  PubMed  Google Scholar 

  22. Fall M, Baranowski AP, Elneil S, et al. EAU guidelines on chronic pelvic pain. Eur Urol. 2010;57:35–48.

    Article  PubMed  Google Scholar 

  23. Berry SH, Bogart LM, Pham C, et al. Development, validation and testing of an epidemiological case definition of interstitial cystitis/painful bladder syndrome. J Urol. 2010;183:1848–52.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Hanno PM, Burks DA, Clemens JQ, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. American Urological Association Education and Research, Inc. J Urol. 2011;185(6):2162–70.

    Article  PubMed  Google Scholar 

  25. Hanno PM, Erickson D, Moldwin R, Faraday MM. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545–53.

    Article  PubMed  Google Scholar 

  26. Leppilahti M, Tammela TL, Huhtala H, et al. Prevalence of symptoms related to interstitial cystitis in women: a population based study in Finland. J Urol. 2002;168:139–43.

    Article  PubMed  Google Scholar 

  27. Clemens JQ, Meenan PR, O’Keeffe Rosetti MC, et al. Prevalence of interstitial cystitis symptoms in a managed care population. J Urol. 2005;174:576–80.

    Article  PubMed  Google Scholar 

  28. Rosenberg MT, Hazzard M. Prevalence of interstitial cystitis symptoms in women: a population based study in the primary care office. J Urol. 2005;174:2231–4.

    Article  PubMed  Google Scholar 

  29. Rosenberg MT, Page S, Hazzard MA. Prevalence of interstitial cystitis in a primary care setting. Urology. 2007;69:48–52.

    Article  PubMed  Google Scholar 

  30. Lifford KL, Curhan GC. Prevalence of painful bladder syndrome in older women. Urology. 2009;73:494–8.

    Article  PubMed  Google Scholar 

  31. Suskind AM, et al. The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND Interstitial Cystitis Epidemiology Male Study. J Urol. 2013;189:141–5.

    Article  PubMed  Google Scholar 

  32. Warren JW, Brown J, Tracy JK, et al. Evidence-based criteria for pain of interstitial cystitis/painful bladder syndrome in women. Urology. 2008;71:444–8.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Warren JW, Diggs C, Brown V, et al. Dysuria at onset of interstitial cystitis/painful bladder syndrome in women. Urology. 2006;68:477–81.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Driscoll A, Teichman JM. How do patients with interstitial cystitis present? J Urol. 2001;166:2118–20.

    Article  CAS  PubMed  Google Scholar 

  35. Peters KM, Carrico DJ, Kalinowski SE, et al. Prevalence of pelvic floor dysfunction in patients with interstitial cystitis. Urology. 2007;70(1):16–8.

    Article  PubMed  Google Scholar 

  36. Alagiri M, Chottiner S, Ratner V, et al. Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology. 1997;49(5A suppl):52–7.

    Article  CAS  PubMed  Google Scholar 

  37. Clauw DJ, Schmidt M, Radulovic D, et al. The relationship between fibromyalgia and interstitial cystitis. J Psychiatr Res. 1997;31:125–31.

    Article  CAS  PubMed  Google Scholar 

  38. Wu EQ, Birnbaum H, Mareva M, et al. Interstitial cystitis: cost, treatment and co-morbidities in an employed population. Pharmacoeconomics. 2006;24:55–65.

    Article  PubMed  Google Scholar 

  39. Clemens JQ, Meenan RT, O’Keeffe-Rosetti MC, et al. Case–control study of medical comorbidities in women with interstitial cystitis. J Urol. 2008;179:2222–5.

    Article  PubMed  Google Scholar 

  40. Warren JW, Howard FM, Cross RK, et al. Antecedent non bladder syndromes in case–control study of interstitial cystitis/painful bladder syndrome. Urology. 2009;73:52–7.

    Article  PubMed  Google Scholar 

  41. Nickel JC, Tripp DA, Pontari M, et al. Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia, and chronic fatigue syndrome. J Urol. 2010;184:1358–63.

    Article  PubMed  Google Scholar 

  42. Nickel JC, Tripp DA, Pontari M, et al. Psychosocial phenotyping in women with interstitial cystitis/painful bladder syndrome: a case control study. J Urol. 2010;183:167–72.

    Article  PubMed  Google Scholar 

  43. Rodriguez MA, Afari N, Buchwald DS, et al. National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Urological Chronic Pelvic Pain: evidence for overlap between urological and non urological unexplained clinical conditions. J Urol. 2009;182:2123–31.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Johnson JE, Johnson KE. Ambiguous chronic illness in women: community health nursing concern. J Community Health Nurs. 2006;23:159–67.

    Article  PubMed  Google Scholar 

  45. Hanno P, Lin A, Nordling J, Nyberg L, et al. Bladder pain syndrome international consultation on incontinence. Neurourol Urodyn. 2009;29:191–8.

    Article  Google Scholar 

  46. Nordling J, Anjum FH, Bade JJ, et al. Primary evaluation of patients suspected of having interstitial cystitis (IC). Eur Urol. 2004;45:662–9.

    Article  CAS  PubMed  Google Scholar 

  47. Warren JW, Van de Merwe JP, Nickel JC. Interstitial cystitis/bladder pain syndrome and non bladder syndromes: facts and hypotheses. J Urol. 2011;78:727–32.

    Article  Google Scholar 

  48. Altman D, Lundholm C, Milsom I, et al. The genetic and environmental contribution to the occurrence of bladder pain syndrome: an empirical approach in a nationwide population sample. Eur Urol. 2011;59:280–5.

    Article  PubMed  Google Scholar 

  49. Wennberg AL, Molander U, Fall M, Edlund C, Peeker R, Milsom I. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women. Eur Urol. 2009;55:783–91.

    Article  PubMed  Google Scholar 

  50. Parsons CL. The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis/overactive bladder, urethral syndrome, prostatitis, and gynaecological chronic pelvic pain. BJU Int. 2010;107:370–5.

    Article  PubMed  Google Scholar 

  51. Evans RJ. Treatment approaches for interstitial cystitis: multimodality therapy. Rev Urol. 2002;4 Suppl 1:S16–20.

    PubMed  PubMed Central  Google Scholar 

  52. Parsons CL, Shaw T, Berecz Z, Su Y, Zupkas P, Argade S. Role of urinary cations in the aetiology of bladder symptoms and interstitial cystitis. BJU Int. 2013;114:286–93.

    Article  Google Scholar 

  53. Chung S-D, Liu H-T, Lin H, Kuo H-C. Elevation of serum C-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder. Neurourol Urodyn. 2011;30:417–20.

    Article  CAS  PubMed  Google Scholar 

  54. Cruz F, Dinis P. Resiniferatoxin and botulinum toxin type A for treatment of lower urinary tract symptoms. Neurourol Urodyn. 2007;26:920–7.

    Article  CAS  PubMed  Google Scholar 

  55. Yoshimura N, Seki S, Chancellor MB, de Groat WC, Ueda T. Targeting afferent hyperexcitability for therapy of the painful bladder syndrome. Urology. 2002;59(5 Suppl 1):61–7.

    Article  PubMed  Google Scholar 

  56. Yoshimura N, Oguchi T, Yokoyama H, et al. Bladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis. Int J Urol. 2014;21 Suppl 1:18–25.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Jacobs BL, Smaldone MC, Tyagi V, et al. Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients. Can J Urol. 2010;17(1):4989–94.

    PubMed  Google Scholar 

  58. Sukiennik A, Carr DB, Bonney I, Marchand JE, Wurm H, Sant GR. The effect of short-term epidural local anesthetic blockade on urinary levels of substance P in interstitial cystitis. Anesth Analg. 2004;98:846–50.

    Article  CAS  PubMed  Google Scholar 

  59. Keller J, Chen Y-K, Lin H-C. Association of bladder pain syndrome/interstitial cystitis with urinary calculus: a nationwide population-based study. Int Urogynecol J. 2013;24:565–71.

    Article  PubMed  Google Scholar 

  60. Sant GR, Kempuraj D, Marchand JE, Theoharides TC. The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology. 2007;69:34–40.

    Article  PubMed  Google Scholar 

  61. Rovner E, Propert KJ, Brensinger C, Wein AJ, Foy M, Kirkemo A, Landis JR, Kusek JW, Nyberg LM. Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Database Study Group. Urology. 2000;56(6):940–5.

    Article  CAS  PubMed  Google Scholar 

  62. Foster Jr HE, Hanno PM, Nickel JC, Payne CK, Mayer RD, Burks DA, Yang CC, Chai TC, Kreder KJ, Peters KM, Lukacz ES, FitzGerald MP, Cen L, Landis JR, Propert KJ, Yang W, Kusek JW, Nyberg LM. Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. J Urol. 2010;183(5):1853–8.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Carrico DJ, Peters KM, Diokno AC. Guided imagery for women with interstitial cystitis: results of a prospective, randomized controlled pilot study. J Altern Complement Med. 2008;14(1):53–60.

    Article  PubMed  Google Scholar 

  64. Shorter B, Lesser M, Moldwin RM, Kushner L. Effect of comestibles on symptoms of interstitial cystitis. J Urol. 2007;178(1):145–52.

    Article  PubMed  Google Scholar 

  65. Rothrock NE, Lutgendorf SK, Kreder KJ, Ratliff T, Zimmerman B. Stress and symptoms in patients with interstitial cystitis: a life stress model. Urology. 2001;57(3):422–7.

    Article  CAS  PubMed  Google Scholar 

  66. Bassaly R, Tidwell N, Bertolino S, Hoyte L, Downes K, Hart S. Myofascial pain and pelvic floor dysfunction in patients with interstitial cystitis. Int Urogynecol J. 2011;22(4):413–8.

    Article  PubMed  Google Scholar 

  67. FitzGerald MP, Payne CK, Lukacz ES, Yang CC, Peters KM, Chai TC, Nickel JC, Hanno PM, Kreder KJ, Burks DA, Mayer R, Kotarinos R, Fortman C, Allen TM, Fraser L, Mason-Cover M, Furey C, Odabachian L, Sanfield A, Chu J, Huestis K, Tata GE, Dugan N, Sheth H, Bewyer K, Anaeme A, Newton K, Featherstone W, Halle-Podell R, Cen L, Landis JR, Propert KJ, Foster Jr HE, Kusek JW, Nyberg LM. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol. 2012;187(6):2113.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Van Ophoven A, Pokupic S, Heinecke A, Hertle L. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol. 2004;172(2):533–6.

    Article  PubMed  Google Scholar 

  69. Sant GR, Propert KJ, Hanno PM, Burks D, Culkin D, Diokno AC, Hardy C, Landis JR, Mayer R, Madigan R, Messing EM, Peters K, Theoharides TC, Warren J, Wein AJ, Steers W, Kusek JW, Nyberg LM. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol. 2003;170(3):810–5.

    Article  CAS  PubMed  Google Scholar 

  70. Yamada T, Murayama T, Andoh M. Adjuvant hydrodistension under epidural anesthesia for interstitial cystitis. Int J Urol. 2003;10(9):463–8.

    Article  PubMed  Google Scholar 

  71. Ottem DP, Teichman JM. What is the value of cystoscopy with hydrodistension for interstitial cystitis? Urology. 2005;66(3):494–9.

    Article  PubMed  Google Scholar 

  72. Chennamsetty A, Khourdaji I, Goike J, Killinger KA, Girdler B, Peters KM. Electrosurgical management of Hunner ulcers in a referral center’s interstitial cystitis population. Urology. 2015;85(1):74–8.

    Article  PubMed  Google Scholar 

  73. Cox M, Klutke JJ, Klutke CG. Assessment of patient outcomes following submucosal injection of triamcinolone for treatment of Hunner’s ulcer subtype interstitial cystitis. Can J Urol. 2009;16(2):4536–40.

    PubMed  Google Scholar 

  74. Payne RA, O’Connor RC, Kressin M, Guralnick ML. Endoscopic ablation of Hunner’s lesions in interstitial cystitis patients. Can Urol Assoc J. 2009;3(6):473–7.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Peters KM, Feber KM, Bennett RC. A prospective, single-blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitis. BJU Int. 2007;100(4):835–9.

    Article  PubMed  Google Scholar 

  76. Peters KM, Konstandt D. Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis. BJU Int. 2004;93(6):777–9.

    Article  CAS  PubMed  Google Scholar 

  77. Zabihi N, Mourtzinos A, Maher MG, Raz S, Rodríguez LV. Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(4):553–7.

    Article  PubMed  Google Scholar 

  78. Powell CR, Kreder KJ. Long-term outcomes of urgency-frequency syndrome due to painful bladder syndrome treated with sacral neuromodulation and analysis of failures. J Urol. 2010;183(1):173–6.

    Article  PubMed  Google Scholar 

  79. Peters KM, Jayabalan N, Bui D, Killinger K, Chancellor M, Tyagi P. Effect of sacral neuromodulation on outcome measures and urine chemokines in interstitial cystitis/painful bladder syndrome patients. Low Urin Tract Symptoms. 2015;7(2):77–83.

    Article  CAS  PubMed  Google Scholar 

  80. Rapp DE, Turk KW, Bales GT, Cook SP. Botulinum toxin type a inhibits calcitonin gene-related peptide release from isolated rat bladder. J Urol. 2006;175(3 Pt 1):1138–42.

    Article  CAS  PubMed  Google Scholar 

  81. Manning J, Dwyer P, Rosamilia A, Colyvas K, Murray C, Fitzgerald E. A multicentre, prospective, randomised, double-blind study to measure the treatment effectiveness of abobotulinum A (AboBTXA) among women with refractory interstitial cystitis/bladder pain syndrome. Int Urogynecol J. 2014;25(5):593–9.

    Article  PubMed  Google Scholar 

  82. Kuo HC, Chancellor MB. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome. BJU Int. 2009;104(5):657–61.

    Article  CAS  PubMed  Google Scholar 

  83. Pinto R, Lopes T, Frias B, Silva A, Silva JA, Silva CM, Cruz C, Cruz F, Dinis P. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur Urol. 2010;58(3):360–5.

    Article  CAS  PubMed  Google Scholar 

  84. Pinto R, Lopes T, Silva J, Silva C, Dinis P, Cruz F. Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome/interstitial cystitis. J Urol. 2013;189(2):548–53. PMID: 23253961.

    Article  CAS  PubMed  Google Scholar 

  85. Chung SD, Kuo YC, Kuo HC. Intravesical onabotulinumtoxin A injections for refractory painful bladder syndrome. Pain Physician. 2012;15(3):197–202.

    PubMed  Google Scholar 

  86. Forrest JB, Payne CK, Erickson DR. Cyclosporine A for refractory interstitial cystitis/bladder pain syndrome: experience of 3 tertiary centers. J Urol. 2012;188(4):1186–91.

    Article  CAS  PubMed  Google Scholar 

  87. Forsell T, Ruutu M, Isoniemi H, Ahonen J, Alfthan O. Cyclosporine in severe interstitial cystitis. J Urol. 1996;155(5):1591–3.

    Article  CAS  PubMed  Google Scholar 

  88. Sairanen J, Forsell T, Ruutu M. Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A. J Urol. 2004;171(6 Pt 1):2138–41.

    Article  CAS  PubMed  Google Scholar 

  89. Rössberger J, Fall M, Jonsson O, Peeker R. Long-term results of reconstructive surgery in patients with bladder pain syndrome/interstitial cystitis: subtyping is imperative. Urology. 2007;70(4):638–42.

    Article  PubMed  Google Scholar 

  90. Head KA. Natural approaches to prevention and treatment of infections of the lower urinary tract. Altern Med Rev. 2008;13(3):227–44.

    PubMed  Google Scholar 

  91. http://www.fda.gov/Drugs/DrugSafety/ucm245011.htm. Accessed Jan 2016.

  92. Webster DC, Brennan T. Use and effectiveness of physical self-care strategies for interstitial cystitis. Nurs Pract. 1994;19(10):55–60.

    Article  CAS  Google Scholar 

  93. Korting GE, Smith SD, Wheeler MA, Weiss RM, Foster Jr HE. A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis. J Urol. 1999;161(2):558–65.

    Article  CAS  PubMed  Google Scholar 

  94. Czarapata BJ. Super-strength, freeze-dried Aloe vera capsules in interstitial cystitis, painful bladder syndrome, chronic pelvic pain, and nonbacterial prostatitis: a double-blind, placebo-controlled crossover trial using Desert Harvest Aloe vera at the Urology Wellness Center, Rockville, Maryland. Proceedings of the NIDDK Scientific Symposium, San Diego, California. National Institutes of Health, Rockville, Maryland. 1995. Accessed Jan 2016.

    Google Scholar 

  95. Katske F, Shoskes DA, Sender M, Poliakin R, Gagliano K, Rajfer J. Treatment of interstitial cystitis with a quercetin supplement. Tech Urol. 2001;7(1):44–6.

    CAS  PubMed  Google Scholar 

  96. Mendelowitz F, Moldwin R. Complementary therapies in the management of interstitial cystitis. In: Sant G, editor. Interstitial cystitis. Philadelphia: Lippincott-Raven; 1997. p. 235–9.

    Google Scholar 

  97. Ripoll E, Mahowald D. Interstitial cystitis and yoga: can it help? Interstitial Cystitis Network. http://www.ic-network.com. Published 2002. Accessed 15 Jan 2016.

  98. Michalsen A, Grossman P, Acil A, Langhorst J, Lüdtke R, Esch T, Stefano GB, Dobos GJ. Rapid stress reduction and anxiolysis among distressed women as a consequence of a three-month intensive yoga program. Med Sci Monit. 2005;11(12):CR555–61.

    PubMed  Google Scholar 

  99. Carter M, Weber T. Body reflexology: healing at your fingertips. Englewood Cliffs: Prentice-Hall; 1994.

    Google Scholar 

  100. Rapkin AJ, Kames LD. The pain management approach to chronic pelvic pain. J Reprod Med. 1987;32:323–7.

    CAS  PubMed  Google Scholar 

  101. Dharmananda S. Treatment of interstitial cystitis with Chinese medicine. Institute for Traditional Medicine. http://www.itmonline.org. Published 2003. Accessed 24 Jan 2016.

  102. Whitmore KE. Complementary and alternative therapies as treatment alternatives for interstitial cystitis. Rev Urol. 2002;4 Suppl 1:S28–35.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Thomas Jefferson University, Section FPMRS, Department of Obstetrics and Gynecology, Philadelphia, PA, USA

    Karolynn Echols FACOG, FPMRS, ABOIM

  2. AtlantiCare Physician Group, AtlantiCare Regional Medical Center, Department of Obstetrics and Gynecology, Atlantic City, NJ, USA

    Tamara Toidze MD, FACOG

  3. Cooper University Hospital, Division of FPMRS, Department of Obstetrics and Gynecology, Camden, NJ, USA

    Gunda Simpkins MSN, MPH

Authors
  1. Karolynn Echols FACOG, FPMRS, ABOIM
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tamara Toidze MD, FACOG
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gunda Simpkins MSN, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karolynn Echols FACOG, FPMRS, ABOIM .

Editor information

Editors and Affiliations

  1. Department of Anesthesiology, Cooper Medical School of Rowan University , Camden, New Jersey, USA

    Michael Sabia

  2. Department of Anesthesiology, Cooper Medical School of Rowan University, Camden, New Jersey, USA

    Jasjit Sehdev

  3. Center for Advanced Pain Management, Hunterdon Medical Center Center for Advanced Pain Management, Flemington, New Jersey, USA

    William Bentley

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Echols, K., Toidze, T., Simpkins, G. (2017). Chronic Pelvic Pain of Urogynecologic Origin. In: Sabia, M., Sehdev, J., Bentley, W. (eds) Urogenital Pain. Springer, Cham. https://doi.org/10.1007/978-3-319-45794-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-45794-9_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-45792-5

  • Online ISBN: 978-3-319-45794-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation